Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
PMID: 20190676
Higher doses reached that plateau later in the trial. In a 112-week step-down trial, participants maintained 21.9% loss on the top dose, 16.6% after stepping down to 5 mg, and 9.9% on placebo
Access this article Similar content being viewed by others Data Availability No datasets were generated or analysed during the current study
All products supplied by NewBioRx are intended strictly for laboratory research and development use only and are not approved for human or veterinary use
US$ 27.66
US$ 23.43
US$ 25.35
US$ 25.78
US$ 20.64
